Work

A Case of Erythrodermic Psoriasis Successfully Treated With Ixekizumab Combined With Low‐Dose Methotrexate to Ensure Sustained Clearance: A Case Report

Year: 2025

Type: article

Abstract: Erythrodermic psoriasis (EP) is a severe type of psoriasis that requires immediate and effective treatment to prevent serious complications. Although recommended as first-line treatment for EP, conventional systemic disease-modifying antirheumatic drugs (csDMARDs) such as methotrexate and/or cyclosporine can sometimes be ineffective or undesirable, hence the use of biologics. However, in cases of refractory disease, biologics may be combined with methotrexate to boost efficacy and optimize outcomes without compromising safety and tolerability.

Source: Case Reports in Dermatological Medicine

DOI: 10.1155/crdm/8810497

Authors: Jennifer Lavina Ngo, Lily Lyralin Tumalad, Patricia Anne Tinio, Rogelio Balagat

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $790

OpenAlex ID: W4410858604

FWCI:

Cites: 14

Cited by:

Related to: 10